56. ベーチェット病 ［臨床試験数：68，薬物数：87（DrugBank：31），標的遺伝子数：36，標的パスウェイ数：113］
Searched query = "Behcet disease", "Behçet disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||JPRN-UMIN000012469||2013/12/02||02/12/2013||Comparison of Adalimumab and Steroid in Intestinal Behcet's disease||Comparison of Adalimumab and Steroid in Intestinal Behcet's disease - Castle Study||Intestinal Behcet's disease||Subcutaneous injection of adalumumab with 160mg at 0 week, 80mg at 2 weeks and 40mg every other week after at 4 weeks continuously.|
Oral administration of prednisolone with 0.6mg/kg/day during from 1 to 2 weeks, and tapering off until 12 weeks with decreasing dosage 5mg/kg/week approximately
|Castle Study Group||NULL||Recruiting||15years-old||Not applicable||Male and Female||50||Not selected||Japan|
|October 2010||30/6/2009||Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease||Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease||Behcet Syndrome;Uveal Disease||Drug: Etanercept, Methotrexate, Prednisolone||Tehran University of Medical Sciences||Wyeth is now a wholly owned subsidiary of Pfizer||Recruiting||16 Years||60 Years||Both||80||N/A||Iran, Islamic Republic of|